Bupropion hydrochloride (JAN/USP)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 37 USDMF, 13 EU WC, 10 KDMF, 33 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

98 Drugs in Development

98 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

210 FDF Dossiers, 136 FDA Orange Book, 43 Europe, 2 Canada, 2 Australia, 8 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 17 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 45 Controlled & Modified Release, 43 Direct Compression, 40 Solubilizers, 37 Thickeners and Stabilizers, 35 Granulation, 29 Taste Masking, 29 Lubricants & Glidants, 28 Film Formers & Plasticizers, 24 Parenteral, 23 Topical, 19 Chewable & Orodispersible Aids, 17 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 11 Emulsifying Agents, 10 Rheology Modifiers, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

96 News #PharmaBuzz

96 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 58 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

12 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 26 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 25 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20711 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31)	BUPROPION HYDROCHLORIDE	150mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC
CARNAUBA WAX(R12CBM0EIZ)
CYSTEINE HYDROCHLORIDE(ZT934N0X4W)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C RED NO. 40(WZB9127XOA)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Bupropion hydrochloride (JAN/USP)